Loading...
Ingevity Corporation
NGVT•NYSE
Basic Materials
Chemicals - Specialty
$45.66
$-0.74(-1.59%)
Ingevity Corporation (NGVT) Financial Performance & Income Statement Overview
Review Ingevity Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-16.88%
↓ 16.88%
Operating Income Growth
-9.82%
↓ 9.82%
Net Income Growth
-7868.52%
↓ 7868.52%
Operating Cash Flow Growth
-37.30%
↓ 37.30%
Operating Margin
20.50%
↑ 20.50%
Gross Margin
34.69%
↑ 34.69%
Net Profit Margin
-26.20%
↓ 26.20%
ROE
-152.32%
↓ 152.32%
ROIC
15.45%
↑ 15.45%
Ingevity Corporation (NGVT) Income Statement & Financial Overview
Review Ingevity Corporation's (NGVT) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $284.00M | $298.80M | $376.90M | $390.60M |
| Cost of Revenue | $170.60M | $196.90M | $247.00M | $275.70M |
| Gross Profit | $113.40M | $101.90M | $129.90M | $114.90M |
| Gross Profit Ratio | $0.40 | $0.34 | $0.34 | $0.29 |
| R&D Expenses | $0.00 | $0.00 | $6.70M | $7.30M |
| SG&A Expenses | $43.10M | $39.40M | $38.70M | $33.90M |
| Operating Expenses | $43.10M | $46.70M | $129.90M | $41.20M |
| Total Costs & Expenses | $213.70M | $255.60M | $291.60M | $316.90M |
| Interest Income | $0.00 | $4.30M | $700000.00 | $900000.00 |
| Interest Expense | $19.40M | $25.50M | $24.50M | $24.10M |
| Depreciation & Amortization | $24.10M | $25.20M | $26.20M | $27.30M |
| EBITDA | $70.30M | $59.90M | -$87.20M | -$283.20M |
| EBITDA Ratio | $0.25 | $0.20 | -$0.23 | -$0.73 |
| Operating Income | $70.30M | $55.20M | $84.50M | $73.70M |
| Operating Income Ratio | $0.25 | $0.18 | $0.22 | $0.19 |
| Other Income/Expenses (Net) | -$43.50M | -$46.40M | -$222.40M | -$409.10M |
| Income Before Tax | $26.80M | $8.80M | -$137.90M | -$334.60M |
| Income Before Tax Ratio | $0.09 | $0.03 | -$0.37 | -$0.86 |
| Income Tax Expense | $6.30M | -$7.80M | -$30.70M | -$50.90M |
| Net Income | $20.50M | $16.60M | -$107.20M | -$283.70M |
| Net Income Ratio | $0.07 | $0.06 | -$0.28 | -$0.73 |
| EPS | $0.56 | $0.46 | -$2.95 | -$7.81 |
| Diluted EPS | $0.56 | $0.45 | -$2.95 | -$7.81 |
| Weighted Avg Shares Outstanding | $36.40M | $36.30M | $36.30M | $36.34M |
| Weighted Avg Shares Outstanding (Diluted) | $36.70M | $36.60M | $36.30M | $36.34M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan